注意:这些药物不能用葡萄糖配 !

2016-02-29 医学之声 医学之声

1. 青霉素  呈酸性的葡萄糖注射液或四环素注射液皆可破坏青霉素的活性。 2. 阿莫西林钠克拉维酸钾 注射用阿莫西林钠克拉维酸钾在含有葡萄糖、葡聚糖或酸性碳酸盐的溶液中会降低稳定性,故注射用阿莫西林钠克拉维酸钾不能与含有上述物质的溶液混合。 3. 氨苄西林 氨苄西林在弱酸性葡萄糖液中分解较快,因此宜用中性液体作溶剂。 4. 厄他

1. 青霉素 

呈酸性的葡萄糖注射液或四环素注射液皆可破坏青霉素的活性。

2. 阿莫西林钠克拉维酸钾

注射用阿莫西林钠克拉维酸钾在含有葡萄糖、葡聚糖或酸性碳酸盐的溶液中会降低稳定性,故注射用阿莫西林钠克拉维酸钾不能与含有上述物质的溶液混合。

3. 氨苄西林

氨苄西林在弱酸性葡萄糖液中分解较快,因此宜用中性液体作溶剂。

4. 厄他培南

注射用厄他培南不得使用含有葡萄糖(α-D-葡萄糖)的稀释液。注射用厄他培南必须在给药前溶解并稀释。

5. 呋塞米

呋塞米为钠盐注射液,碱性较高,故静脉注射时宜用氯化钠注射液稀释,而不宜用葡萄糖注射液稀释。

6. 硫辛酸

硫辛酸注射液不能与葡萄糖溶液、林格氏溶液及所有可能与硫基或二硫键起反应的溶液配伍使用。

7. 依达拉奉

依达拉奉禁止与含糖的输注液、高能量输液、氨基酸制剂、抗癫痫药及坎利酸钾等配伍使用。

8. 地西泮

安定与生理盐水或少量糖水产生白色沉淀。

9. 重组人组织纤维蛋白溶酶原激活剂

配制的注射用重组人组织纤维蛋白溶酶原激活剂溶液可用灭菌生理盐水(0.9%)按1:5稀释,但不能继续使用注射用水或用碳水化合物注射液如葡萄糖作进一步稀释。

10. 氨力农

氨力农必须先用氨力农注射溶剂溶解,再以生理盐水稀释后使用,不能用含右旋糖酐或葡萄糖的溶液稀释。

11. 克拉屈滨

克拉屈滨注射液不得以含有葡萄糖的注射液作为稀释剂,因葡萄糖可以促进克拉屈滨的分解。

12. 普鲁卡因

普鲁卡因不宜与葡萄糖液配伍,因可使其局麻作用降低。

13. 羟喜树碱

羟喜树碱注射液不宜用葡萄糖液稀释。

14. 替奈普酶

替奈普酶只能溶于0.9%氯化钠注射液中,不能使用葡萄糖溶液进行配置。

15. 生长抑素

醋酸生长抑素不应与葡萄糖或果糖溶液混合。

16. 抗人T-淋巴细胞兔免疫球蛋白

抗人T-淋巴细胞兔免疫球蛋白不能与葡萄糖,肝素钠,血液,血源性制品和含脂质的溶液混合使用。

17. 腺苷钴胺

注射用腺苷钴胺与葡萄糖液有配伍禁忌。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=66630, encodeId=cc726663014, content=熟记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160927/IMG57EA96AC605D49387.jpg, createdBy=7e381677945, createdName=Channel J, createdTime=Tue Mar 01 17:53:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66535, encodeId=f97366535ab, content=牢记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:56:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66443, encodeId=c7b56644339, content=必须熟记, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Tue Mar 01 10:20:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66376, encodeId=0032663e6ff, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bda71672968, createdName=唐一可, createdTime=Mon Feb 29 23:52:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66353, encodeId=2da46635337, content=依达拉奉禁止与含糖的输注液、高能量输液、氨基酸制剂、抗癫痫药及坎利酸钾等配伍使用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Feb 29 21:19:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66348, encodeId=c41466348c3, content=大部分都知道啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Mon Feb 29 20:53:00 CST 2016, time=2016-02-29, status=1, ipAttribution=)]
    2016-03-01 Channel J

    熟记在心

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=66630, encodeId=cc726663014, content=熟记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160927/IMG57EA96AC605D49387.jpg, createdBy=7e381677945, createdName=Channel J, createdTime=Tue Mar 01 17:53:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66535, encodeId=f97366535ab, content=牢记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:56:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66443, encodeId=c7b56644339, content=必须熟记, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Tue Mar 01 10:20:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66376, encodeId=0032663e6ff, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bda71672968, createdName=唐一可, createdTime=Mon Feb 29 23:52:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66353, encodeId=2da46635337, content=依达拉奉禁止与含糖的输注液、高能量输液、氨基酸制剂、抗癫痫药及坎利酸钾等配伍使用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Feb 29 21:19:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66348, encodeId=c41466348c3, content=大部分都知道啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Mon Feb 29 20:53:00 CST 2016, time=2016-02-29, status=1, ipAttribution=)]
    2016-03-01 破风4392

    牢记在心

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=66630, encodeId=cc726663014, content=熟记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160927/IMG57EA96AC605D49387.jpg, createdBy=7e381677945, createdName=Channel J, createdTime=Tue Mar 01 17:53:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66535, encodeId=f97366535ab, content=牢记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:56:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66443, encodeId=c7b56644339, content=必须熟记, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Tue Mar 01 10:20:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66376, encodeId=0032663e6ff, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bda71672968, createdName=唐一可, createdTime=Mon Feb 29 23:52:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66353, encodeId=2da46635337, content=依达拉奉禁止与含糖的输注液、高能量输液、氨基酸制剂、抗癫痫药及坎利酸钾等配伍使用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Feb 29 21:19:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66348, encodeId=c41466348c3, content=大部分都知道啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Mon Feb 29 20:53:00 CST 2016, time=2016-02-29, status=1, ipAttribution=)]
    2016-03-01 老段

    必须熟记

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=66630, encodeId=cc726663014, content=熟记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160927/IMG57EA96AC605D49387.jpg, createdBy=7e381677945, createdName=Channel J, createdTime=Tue Mar 01 17:53:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66535, encodeId=f97366535ab, content=牢记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:56:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66443, encodeId=c7b56644339, content=必须熟记, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Tue Mar 01 10:20:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66376, encodeId=0032663e6ff, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bda71672968, createdName=唐一可, createdTime=Mon Feb 29 23:52:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66353, encodeId=2da46635337, content=依达拉奉禁止与含糖的输注液、高能量输液、氨基酸制剂、抗癫痫药及坎利酸钾等配伍使用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Feb 29 21:19:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66348, encodeId=c41466348c3, content=大部分都知道啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Mon Feb 29 20:53:00 CST 2016, time=2016-02-29, status=1, ipAttribution=)]
    2016-02-29 唐一可

    有用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=66630, encodeId=cc726663014, content=熟记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160927/IMG57EA96AC605D49387.jpg, createdBy=7e381677945, createdName=Channel J, createdTime=Tue Mar 01 17:53:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66535, encodeId=f97366535ab, content=牢记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:56:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66443, encodeId=c7b56644339, content=必须熟记, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Tue Mar 01 10:20:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66376, encodeId=0032663e6ff, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bda71672968, createdName=唐一可, createdTime=Mon Feb 29 23:52:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66353, encodeId=2da46635337, content=依达拉奉禁止与含糖的输注液、高能量输液、氨基酸制剂、抗癫痫药及坎利酸钾等配伍使用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Feb 29 21:19:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66348, encodeId=c41466348c3, content=大部分都知道啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Mon Feb 29 20:53:00 CST 2016, time=2016-02-29, status=1, ipAttribution=)]
    2016-02-29 medcardio

    依达拉奉禁止与含糖的输注液、高能量输液、氨基酸制剂、抗癫痫药及坎利酸钾等配伍使用。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=66630, encodeId=cc726663014, content=熟记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160927/IMG57EA96AC605D49387.jpg, createdBy=7e381677945, createdName=Channel J, createdTime=Tue Mar 01 17:53:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66535, encodeId=f97366535ab, content=牢记在心, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:56:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66443, encodeId=c7b56644339, content=必须熟记, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Tue Mar 01 10:20:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66376, encodeId=0032663e6ff, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bda71672968, createdName=唐一可, createdTime=Mon Feb 29 23:52:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66353, encodeId=2da46635337, content=依达拉奉禁止与含糖的输注液、高能量输液、氨基酸制剂、抗癫痫药及坎利酸钾等配伍使用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Mon Feb 29 21:19:00 CST 2016, time=2016-02-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66348, encodeId=c41466348c3, content=大部分都知道啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Mon Feb 29 20:53:00 CST 2016, time=2016-02-29, status=1, ipAttribution=)]
    2016-02-29 sillywu

    大部分都知道啦

    0

相关资讯

PNAS:家暴与血液中葡萄糖水平有关?

一项为期21天的研究对已婚夫妇每天的血糖水平进行了检测,该研究发现,与自我控制有关的血液葡萄糖的减少与参与者攻击其配偶的行为的增加有相关性。自我控制需要以血糖形式存在的能量,而这种能量可能随着时间推移而耗尽,导致自我控制的削弱。有时候指向配偶的攻击冲动可能作为自我控制的失效而出现。 Brad Bushman及其同事在21天里测试了107对已婚配偶的上午和下午的血糖水平。在每一天结束的时候,受试者要

JCI:减肥有望了!科学家发现驱动机体摄入葡萄糖的大脑机制

葡萄糖是一种碳水化合物的组分,其也是大脑细胞所利用的主要能量源,近日,来自伦敦帝国理工学院的研究人员通过对大鼠进行研究鉴别出了一种新型机制,这种机制揭示了进入到大脑中的葡萄糖含量,以及刺激动物在大脑中缺少葡萄糖时主动寻找葡萄糖的能力,相关研究发表于国际杂志Journal of Clinical Investigation上。研究人员认为这种机制在驱动人类偏爱糖类和淀粉类食物中扮演着重要角色,Jam

Nature:揭示二甲双胍降糖新机制

  《自然》(Nature)杂志近期发表的一项研究揭示了二甲双胍潜在的降糖新机制。此前的理论认为二甲双胍通过激活AMPK从而减少肝脏葡萄糖合成,而新的研究表明,二甲双胍通过诱导AMP和抑制腺苷酸环化酶的核苷酸在肝细胞内聚集,降低cAMP和PKA活性,PKA关键蛋白磷酸化步骤被阻止,因而肝细胞胰高血糖素依赖的葡萄糖输出被抑制。   研究由宾夕法尼亚大学Perelman医学院糖尿病、肥胖和代谢

Nature:葡萄糖与心律不齐之间的联系

在心衰竭过程中,名为“Ca2+ /钙调蛋白依赖性蛋白激酶-II”(CaMKII)的酶被自主激发,从而有可能破坏离子通道的门控和钙的处理。这篇文章提出,由葡萄糖诱导的CaMKII激发在糖尿病中也许对心脏病理有贡献。作者发现,高糖会在一个特定残基上诱导CaMKII被“O-linked N-acetylglucosamine (O-GlcNAc)”共价修饰。这会激发CaMKII,增强自发钙释放事件,后者

Nature :大脑在葡萄糖代谢中所起的作用

胰岛素及其对葡萄糖平衡的诸多效应的发现,长期以来决定着我们对糖尿病及其治疗的认识。 但我们对大脑的关注却要少得多——除了感觉以及对低血糖做出反应外,大脑传统上被认为在这方面只起一个小作用。【原文下载】 这篇Review文章总结新发现的关于存在一个与胰岛共同作用来降低血糖的、以大脑为中心的血糖调控系统的证据。以上两个调控系统以广泛的重叠和冗余为特点,所以二者中的缺陷也许都是罹患糖尿病所必需的。